Construction of a Prognostic Gene Signature Associated with Immune Infiltration in Glioma: A Comprehensive Analysis Based on the CGGA

Figure 10

(a) KM survival analysis of the survival difference between the low- and high-risk groups in the external cohort. (b) ROC curve shows the prediction efficiency of the signature in the external cohort. (c–k) Confirmation of the signature via patient stratification based on WHO grade, IDH1 status, 1p/19q codeletion status, and MGMT promoter methylation status in the external cohort.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)